Intellia Therapeutics, Inc. NTLA lost 21.6% in a week as investors were disappointed with the company’s plans for portfolio ...

Apple is no longer the top smartphone seller in China, overtaken by Vivo and Huawei, with a 17% market share decline in 2024.

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...

Apple’s (AAPL) annual shipments in China declined 17% in 2024, with Huawei and Vivo overtaking the iPhone maker in market ...

The market share of Apple in China sees decline, dropping from 19% to 15% in 2024. Vivo and Huawei capture the top spots with ...

Premiering on January 18 at 7 PM on National Geographic Channel, this series follows four leading photographers as they capture India’s breathtaking terrain.

The Vivo V50 is expected to debut soon in the global market. According to a recent report, this phone is a rebranded version ...

The Magic7 Pro is another entry in a long list of high-end phones we've been getting lately - 2025 flagships with ...

Vivo has announced an official price cut for two of its smartphones: the Vivo T3 Pro and the Vivo T3 Ultra, both of which ...

The Honor Magic 7 Pro brings an impressive Periscope zoom lens: 200-megapixel, f/2.6 aperture, 1/1.4-inch image sensor size.